USPTO serial 99557550
CLEAR CROSSING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STEINPFAD, SARAH E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with CLEAR CROSSING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sheila Fox Morrison
Sheila Fox Morrison Davis Wright Tremaine LLP560 SW 10th Avenue, Suite 700Portland, OR 97205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | drug delivery agents consisting of compounds that facilitate delivery of wide range of pharmaceuticals; drug delivery agents in the form of powders and liquids that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that improve the efficacy of other drug delivery agents, all to facilitate the delivery of a wide range of pharmaceuticals; Pharmaceutical preparations in the nature of drug delivery agents consisting of compounds for intracellular delivery of drugs or therapeutic substances; drug delivery agents consisting of compounds for intracellular delivery of biological or chemical compounds for biological research | ACTIVE | — |
| 040 | biomanufacturing services of peptides for others in the nature of peptide synthesis for biological and medical research; biomanufacturing services of peptides for others in the nature of peptide synthesis for manufacturers of biological and medical research products | ACTIVE | — |
| 042 | pharmaceutical research and development; biochemical research and development; research and development in the field of drug delivery and drug delivery systems; chemical analysis of biological and chemical compounds; chemical analysis services; scientific and technological services, namely, product design and development in the field of peptide synthesis for biological and medical research; scientific and technological services, namely, laboratory services for biomanufacturing peptides in the nature of peptide synthesis for manufacturers of biological and medical research products; scientific and technological services, namely, biological and medical research in the field of peptide synthesis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Endorel Biosciences LLC
- Other trademarks owned by Endorel Biosciences LLC
- Other trademarks owned by CLEAR CROSSING BIOSCIENCES LLC
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named CLEAR CROSSING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 28, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 20, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 22, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 6, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 6, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 6, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 1, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2025 | NWAP | NEW APPLICATION ENTERED | — |